|
|
 |
|
Viewing report
|
|
|
|
Multiple Sclerosis Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., April 2010, Pages: 430
This report analyzes the worldwide markets for Multiple Sclerosis Therapeutics in US$ Billion.
The report provides separate comprehensive analytics for the US, Japan, Europe and Rest of World.
Annual estimates and forecasts are provided for each region for the period 2006 through 2015.
The report profiles 45 companies including Bayer Schering Pharma AG, Biogen Idec Inc., Elan Pharmaceuticals, Inc., Genzyme Corp, Merck Serono SA, Novartis AG, Sanofi-Aventis SA, and Teva Pharmaceuticals Industries Limited.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Thought Leader Insight & Analysis Report - Multiple Sclerosis Q2 2010
Thought Leader Insight & Analysis Report - Multiple Sclerosis Q3 2011
Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report
Multiple Myeloma Therapeutics - Global Strategic Business Report
Growth Factors (Blood And Tissue) - Global Strategic Business Report
Growth Factors ( Blood And Tissue ) - Global Strategic Business Report
Kidney Cancer Drugs - Global Strategic Business Report
Hepatitis C Virus and Therapeutics - Global Strategic Business Report
Tinea Pedis (Athletes Foot) - Global Strategic Business Report
Monoclonal Antibody Based Products - Global Strategic Business Report
|
|
|
|
